wbi@bwh.harvard.edu
Bi Lab
MENINGIOMA REGISTRY
← Bi Lab

Predicting brain tumor recurrence: development and validation of a DNA-methylation based nomogram in meningioma

EGAS00001003490, EGAD00010001687Nassiri et al., 2019
View on EGA study page ↗

Overview

Modality
DNA methylation (array)
Sample count
280
Patient count
280
Institution
Princess Margaret Cancer Centre, University Health Network, Toronto (International Consortium on Meningiomas, multi-institutional)
Corresponding author
Kenneth D. Aldape / Gelareh Zadeh
Platform
Illumina (array type unspecified in live metadata)
Access type
controlled
Tissue preservation
Not reported
WHO edition
Not reported

Cohort detail

Grade breakdown
Not reported
Sex distribution
Not reported
Age distribution
Not reported
Anatomic location
Not reported
Brain invasion
Not reported
Normal/control tissue
None

Priority attributes

Large cohort (top quartile)Outcome/survival dataPeer-reviewed

Publications

  • Nassiri F, et al. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-Oncology, 2019. PMID 31158293 · DOI

Sources

  • EGA study page
    https://ega-archive.org/studies/EGAS00001003490
  • EGA dataset page
    https://ega-archive.org/datasets/EGAD00010001687
  • PubMed
    https://pubmed.ncbi.nlm.nih.gov/31158293/
  • DOI
    https://doi.org/10.1093/neuonc/noz061